|
EXP000601
|
Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRN…
|
2016 |
P-(R8)9.5-FITC
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000602
|
Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRN…
|
2016 |
P-(R8)9.5-FITC + chloroquine
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000603
|
Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRN…
|
2016 |
P-(R8)8.6-(HA2)7.6-FITC
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000604
|
Deciphering the internalization mechanism of WRAP:siRNA nanoparticles
|
2020 |
WRAP1
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000605
|
Deciphering the internalization mechanism of WRAP:siRNA nanoparticles
|
2020 |
WRAP5
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000606
|
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucl…
|
2019 |
r8-PNA
|
PNA (antisense)
|
yes |
yes |
|
no |
no |
|
EXP000607
|
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucl…
|
2019 |
Deca-r8-PNA
|
PNA (antisense)
|
yes |
yes |
|
no |
no |
|
EXP000608
|
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucl…
|
2019 |
r8-AF-PNA
|
PNA (antisense)
|
yes |
yes |
|
no |
no |
|
EXP000609
|
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucl…
|
2019 |
Deca-r8-AF-PNA
|
PNA (antisense)
|
yes |
yes |
|
no |
no |
|
EXP000610
|
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucl…
|
2019 |
Deca-r8-PNA2
|
PNA (antisense)
|
yes |
yes |
|
no |
no |
|
EXP000611
|
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucl…
|
2019 |
r8-PNAmm
|
PNA (antisense)
|
yes |
no |
|
no |
no |
|
EXP000612
|
Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucl…
|
2019 |
Deca-r8-PNAmm
|
PNA (antisense)
|
yes |
no |
|
no |
no |
|
EXP000613
|
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancin…
|
2022 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000614
|
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancin…
|
2022 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000615
|
Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides
|
2025 |
PF14
|
SCO / siRNA / miRNA
|
yes |
yes |
|
no |
no |
|
EXP000616
|
Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides
|
2025 |
PF14-Lys
|
SCO / siRNA / miRNA
|
yes |
yes |
|
no |
no |
|
EXP000617
|
Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides
|
2025 |
PF14-Lys
|
miRNA
|
yes |
|
|
yes |
yes |
|
EXP000618
|
Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides
|
2025 |
PF14-Dab
|
SCO / siRNA / miRNA
|
yes |
yes |
|
no |
no |
|
EXP000619
|
Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides
|
2025 |
PF14-R7
|
SCO / siRNA / miRNA
|
yes |
no |
|
no |
no |
|
EXP000620
|
Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides
|
2025 |
PF14-R19
|
SCO / siRNA / miRNA
|
yes |
no |
|
no |
no |
|
EXP000621
|
Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides
|
2025 |
PF14-S13
|
SCO / siRNA / miRNA
|
yes |
no |
|
no |
no |
|
EXP000622
|
Tumor suppressor protein-inspired peptide for siRNA delivery and synergistic ca…
|
2025 |
CPP44
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000623
|
Tumor suppressor protein-inspired peptide for siRNA delivery and synergistic ca…
|
2025 |
CPP44
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP000624
|
WRAP-based nanoparticles for siRNA delivery in zebrafish embryos by simple bath…
|
2025 |
WRAP1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000625
|
WRAP-based nanoparticles for siRNA delivery in zebrafish embryos by simple bath…
|
2025 |
WRAP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000626
|
WRAP-based nanoparticles for siRNA delivery in zebrafish embryos by simple bath…
|
2025 |
WRAP1
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP000627
|
Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparti…
|
2021 |
MMP9-switchable CPP (R9-PVGLIG-EGGEGGEGG)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000628
|
Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparti…
|
2021 |
MMP9-switchable CPP (R9-PVGLIG-EGGEGGEGG)
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP000629
|
Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-bas…
|
2018 |
PVBLG-8
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000630
|
Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-bas…
|
2018 |
PVBLG-8
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP000631
|
siRNA–cell-penetrating peptide complexes as a combinatorial therapy against chr…
|
2017 |
pepR
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000632
|
siRNA–cell-penetrating peptide complexes as a combinatorial therapy against chr…
|
2017 |
pepM
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000633
|
Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Pepti…
|
2019 |
P1-9R
|
antisense oligonucleotide (AON)
|
yes |
yes |
yes |
no |
no |
|
EXP000634
|
Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery
|
2022 |
HELP
|
DNA / siRNA / mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000635
|
Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery
|
2022 |
HELP-4H
|
DNA / siRNA / mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000636
|
Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery
|
2022 |
HELP-4H-D1
|
DNA / siRNA / mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000637
|
Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery
|
2022 |
HELP-4H-D2
|
DNA / siRNA / mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000638
|
Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery
|
2022 |
HELP-4H-D3
|
DNA / siRNA / mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000639
|
Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery
|
2022 |
LAH4-L1
|
DNA / siRNA / mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000640
|
Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for…
|
2016 |
PI
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000641
|
Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for…
|
2016 |
PII
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000642
|
Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for…
|
2016 |
PIII
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000643
|
Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for…
|
2016 |
PIV
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000644
|
Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for…
|
2016 |
PV
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000645
|
Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for…
|
2016 |
PI-acetamide
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000646
|
Comparison of the Efficiency of Complexes Based on S413-PV Cell-Penetrating Pep…
|
2013 |
S413-PV
|
siRNA and plasmid DNA
|
yes |
no |
|
no |
no |
|
EXP000647
|
Comparison of the Efficiency of Complexes Based on S413-PV Cell-Penetrating Pep…
|
2013 |
H5-S413-PV
|
siRNA and plasmid DNA
|
yes |
yes |
|
no |
no |
|
EXP000648
|
Comparison of the Efficiency of Complexes Based on S413-PV Cell-Penetrating Pep…
|
2013 |
S413-PVscr
|
siRNA and plasmid DNA
|
yes |
no |
|
no |
no |
|
EXP000649
|
Comparison of the Efficiency of Complexes Based on S413-PV Cell-Penetrating Pep…
|
2013 |
S413-PVrev
|
siRNA and plasmid DNA
|
yes |
no |
|
no |
no |
|
EXP000650
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KK-(EK)4-lipid
|
none (uptake model)
|
yes |
yes |
|
no |
no |
|
EXP000651
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
EK-(EK)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000652
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
K-(EK)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000653
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KKK-(EK)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000654
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KKKK-(EK)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000655
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
RR-(EK)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000656
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
GKK-(EK)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000657
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KKG-(EK)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000658
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KK-(EK)1-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000659
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KK-(EK)2-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000660
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KK-(EK)3-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000661
|
Investigation of enhanced intracellular delivery of nanomaterials modified with…
|
2023 |
KK-(SG)4-lipid
|
none (uptake model)
|
yes |
no |
|
no |
no |
|
EXP000662
|
Delivery of antisense oligonucleotides for splice-correction of androgen recept…
|
2022 |
PF14
|
antisense oligonucleotide (AON)
|
yes |
yes |
|
no |
no |
|
EXP000663
|
Delivery of antisense oligonucleotides for splice-correction of androgen recept…
|
2022 |
hLF
|
antisense oligonucleotide (AON)
|
yes |
no |
|
no |
no |
|
EXP000664
|
Delivery of antisense oligonucleotides for splice-correction of androgen recept…
|
2022 |
L-R9
|
antisense oligonucleotide (AON)
|
yes |
no |
|
no |
no |
|
EXP000665
|
Delivery of antisense oligonucleotides for splice-correction of androgen recept…
|
2022 |
D-r9
|
antisense oligonucleotide (AON)
|
yes |
no |
|
no |
no |
|
EXP000666
|
Cell mimetic liposomal nanocarriers for tailored delivery of vascular therapeut…
|
2019 |
R8-LDS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000667
|
Cell mimetic liposomal nanocarriers for tailored delivery of vascular therapeut…
|
2019 |
R8+DAG
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000668
|
Cell mimetic liposomal nanocarriers for tailored delivery of vascular therapeut…
|
2019 |
R8+PS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000669
|
Cell mimetic liposomal nanocarriers for tailored delivery of vascular therapeut…
|
2019 |
R8+DAG+PS
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000670
|
Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arre…
|
2024 |
EB1
|
siRNA
|
yes |
yes |
no |
no |
no |
|
EXP000671
|
Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arre…
|
2024 |
MPG-DNLS
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000672
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
cRGD
|
siRNA
|
yes |
yes |
no |
no |
no |
|
EXP000673
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
cRGD
|
siRNA
|
no |
|
no |
yes |
no |
|
EXP000674
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
TriRGD
|
siRNA
|
yes |
yes |
no |
no |
no |
|
EXP000675
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
TriRGD
|
siRNA
|
no |
|
no |
yes |
no |
|
EXP000676
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
cRGD
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000677
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
cRGD
|
siRNA
|
no |
|
yes |
yes |
no |
|
EXP000678
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
TriRGD
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000679
|
Direct Cytosolic Delivery of siRNA Conjugates: A Paradigm in Antiangiogenic The…
|
2025 |
TriRGD
|
siRNA
|
no |
|
yes |
yes |
yes |
|
EXP000680
|
Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery
|
2014 |
RRRRRRGGRRRRG
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000681
|
Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery
|
2014 |
RRRRRRGGRRRRG
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000682
|
Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptid…
|
2016 |
L-FKFE
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000683
|
Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptid…
|
2016 |
L-FKFE
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000684
|
Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptid…
|
2016 |
D-FKFE
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000685
|
Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptid…
|
2016 |
D-FKFE
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000686
|
Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptid…
|
2016 |
WR4
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000687
|
Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptid…
|
2016 |
WR4
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000688
|
Rationally designed cationic amphiphilic peptides for selective gene delivery t…
|
2022 |
IK-13
|
siRNA / antisense ODN
|
yes |
yes |
|
no |
no |
|
EXP000689
|
Rationally designed cationic amphiphilic peptides for selective gene delivery t…
|
2022 |
LK-13
|
siRNA / antisense ODN
|
yes |
no |
|
no |
no |
|
EXP000690
|
Rationally designed cationic amphiphilic peptides for selective gene delivery t…
|
2022 |
IR-13
|
siRNA / antisense ODN
|
yes |
yes |
|
no |
no |
|
EXP000691
|
Rationally designed cationic amphiphilic peptides for selective gene delivery t…
|
2022 |
LR-13
|
siRNA / antisense ODN
|
yes |
no |
|
no |
no |
|
EXP000692
|
Rationally designed cationic amphiphilic peptides for selective gene delivery t…
|
2022 |
CI-15
|
siRNA / antisense ODN
|
yes |
yes |
|
no |
no |
|
EXP000693
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000694
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000695
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W1-2L
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000696
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W1-Lm
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000697
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W5-2L
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000698
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W5-2Lm
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000699
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W5-4L
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000700
|
WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with …
|
2021 |
W1-4R
|
siRNA
|
yes |
no |
|
no |
no |